(lp0
S'The Worst Mistakes Abiomed, Inc. Investors Can Make Right Now Motley Fool - Apr 5, 2016 Lately, Abiomed  investors have seen their shares bounce around like a kid on a trampoline, mainly because the company is at an unpredictable crossroads.'
p1
aS"How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? Motley Fool - Apr 13, 2016 During Abiomed's third quarter, which ended Dec. 31, U.S. patient utilization of Abiomed's tiny heart pumps soared 45% over the same period the previous year."
p2
aS'Read This Before You Sell Abiomed, Inc. Stock Motley Fool - Mar 30, 2016 Over the past five years, Abiomed  shareholders watched with glee as their investment grew more than 600%, as of last summer.'
p3
aS'Why Abiomed, Inc. Shares Were Sent Soaring 137% in 2015 Motley Fool - Jan 8, 2016 What: Rapidly growing sales of its Impella product line of heart catheters, sensors, and pumps led to shares of Abiomed  sky-rocketing 137.2% higher last year, according to Capital IQ.'
p4
aS'Why Abiomed Inc. Shares Crashed 12% Today Motley Fool - Feb 8, 2016 What: Days after reporting better-than-expected financial results for its fiscal third quarter of 2016, shares in Abiomed  tumbled 12.5% today.'
p5
aS"Abiomed: Clear Path To Growth, Shares Remain Substantially Undervalued Seeking Alpha - Jun 2, 2016 ABIOMED's shares are up heavily in the past two years, but two issues have weighed on the stock recently. SHIELD II study puts the company's devices head-to-head against St. Jude Medical, a larger entity."
p6
aS'Abiomed: Excellent Recent Results, But Stay Cautious Seeking Alpha - Oct 3, 2016 Abiomed  has had a rather successful run since my initial coverage back in early June, with shares up 25% over the past four months.'
p7
aS'Stock Update: Looking at the Levels for ABIOMED, Inc.  Davidson Register - 23 hours ago ABIOMED, Inc.  has a current Value Composite Score of 69. Using a scale from 0 to 100, a lower score would indicate an undervalued company and a higher score would signal an expensive or overvalued company.'
p8
aS'ABIOMED, Inc.  Recent Ownership Changes Post Analyst - Mar 16, 2017 ABIOMED, Inc.  reached 47.52% versus a 1-year low price of $83.36. The stock was last seen 2.02% higher, reaching at $122.97 on Mar. 15, 2017.ABIOMED, Inc.  Receives Consensus Rating of Buy from Brokerages - Chaffey BreezeLowest EPS Projection Of ABIOMED, Inc.  At $0.43 - Enterprise Leader'
p9
aS'Abiomed - Great Business, Great Patient Outcomes, Great Investment Opportunity? Seeking Alpha - Dec 29, 2016 Abiomed has developed a great solution for heart products, making a real change for patients and long term investors. While the future looks bright, it can be questioned if too much good news is priced in after shares have risen a factor of 5 times in ...'
p10
a.